How much does Wegovy cost with Medicare in 2026?

With Medicare's GLP-1 Bridge program (starting July 1, 2026), eligible seniors pay a flat $50 per month for Wegovy, regardless of dose. Without the Bridge, Wegovy's retail price is approximately $1,300-1,400 per month. The Bridge does not count toward your Part D deductible or annual out-of-pocket cap.

Does the $50 Wegovy copay change at different doses?

No. CMS sets the Bridge copay at a flat $50 per month regardless of which dose you are on. It is the same whether you are starting at 0.25mg or maintaining at the maximum 2.4mg dose. The copay also stays the same across all coverage phases.

Can I use a Wegovy coupon with Medicare?

No. Federal law prohibits manufacturer coupons (like Novo Nordisk's Wegovy savings card) from being used with Medicare benefits. Medicare beneficiaries who do not qualify for the Bridge but have limited income can apply for the NovoCare patient assistance program instead.

Why is Wegovy so expensive without insurance?

Wegovy's retail price reflects manufacturing complexity (peptide drugs are sophisticated to produce), patent protection through the 2030s, ongoing R&D costs, and global demand. Medicare's newer drug price negotiation authority has not yet covered weight-loss GLP-1s.

What happens to my Wegovy cost when the Bridge ends in 2027?

The Bridge currently runs through December 31, 2027. If Congress does not extend it, the $50 copay disappears and your effective cost could jump to $1,300+ per month. Several bills have been proposed to extend the program but none have passed yet.

How Much Does Wegovy Cost on Medicare in 2026?

The Short Answer

With Medicare's GLP-1 Bridge program (starting July 1, 2026), eligible seniors pay $50 per month for Wegovy — flat rate, regardless of dose or coverage phase. Without the Bridge, Wegovy's retail price is approximately $1,300-1,400 per month.

The difference is dramatic. This single coverage change is the most consequential thing to happen to GLP-1 affordability for seniors since the drugs were approved.

The $50 Bridge Price — How It Works

CMS sets the Bridge copay at $50 per month for a 28-day supply. Key details:

Flat across all doses — same $50 whether you are on the starter dose or the maximum 2.4mg
Flat across coverage phases — no deductible, no donut hole, no catastrophic phase changes
Same $50 for the injection or the tablet — both Wegovy forms qualify
Does NOT count toward your Part D deductible — the Bridge operates outside the normal Part D structure
Does NOT count toward the $2,100 annual out-of-pocket maximum for 2026

This means if you fill 12 monthly prescriptions across the year, your total annual cost for Wegovy is $600 — about half a percent of the retail price.

Who Qualifies for the $50 Price

To pay the Bridge copay, you need:

Medicare Part D enrollment — either standalone Part D or Medicare Advantage with drug coverage (MA-PD)
A qualifying BMI tier:
- Tier 1: BMI 35 or higher (no additional condition required)
- Tier 2: BMI 30+ with heart failure, uncontrolled hypertension, or chronic kidney disease stage 3a+
- Tier 3: BMI 27+ with prediabetes, prior heart attack/stroke, or peripheral artery disease
An approved prior authorization submitted by your doctor to CMS

Take our 2-minute eligibility quiz to check whether you qualify.

Without the Bridge — What Wegovy Actually Costs

If you do not qualify for the Bridge, here is what you face:

Retail Cash Price

Wegovy's list price (set by manufacturer Novo Nordisk) is approximately:

$1,349 per month as of 2026 (varies slightly by pharmacy)
$16,188 per year at retail

This is the price uninsured patients pay, and the price most Medicare beneficiaries would see if Wegovy were not on their Part D formulary for the conditions they have.

Discount Card Prices (GoodRx, etc.)

Discount cards can reduce the cash price to roughly:

$1,000-1,200 per month depending on pharmacy and card
Better than retail, but still not affordable for most seniors on fixed incomes

Manufacturer Coupon

Novo Nordisk offers a savings card for commercially insured patients — but this card is not valid for Medicare beneficiaries. Federal law prohibits manufacturer coupons from being used with Medicare. So if you are on Medicare, this option is closed to you.

Patient Assistance Program (PAP)

Novo Nordisk's NovoCare patient assistance program offers free or significantly reduced Wegovy for low-income patients who cannot afford it. Eligibility is income-based and requires application. For Medicare beneficiaries who do not qualify for the Bridge but have limited income, this is often the most realistic option.

Visit novocare.com or call 1-866-310-7549 to check eligibility.

Why the Cost Is So High

Wegovy is expensive for several reasons:

Long FDA approval process and clinical trials — billions in R&D
Manufacturing complexity — semaglutide is a peptide that requires sophisticated production
Patent protection — generic semaglutide will not be available in the US until the 2030s at earliest
Demand pressure — global shortage conditions through 2023-2024 supported high prices
No price negotiation — Medicare's newer drug price negotiation authority (under the Inflation Reduction Act) has not yet covered weight-loss GLP-1s

The Bridge does not change the underlying retail price — it represents CMS paying the difference between the $50 copay and the negotiated Bridge rate (which CMS keeps confidential).

Cost Comparison vs Other GLP-1s

For reference, here are typical 2026 monthly costs:

Drug	Retail	Medicare Bridge	Standard Part D (diabetes)
Wegovy	$1,350	$50	Not covered for weight loss
Zepbound	$1,060	$50	Not covered for weight loss
Ozempic	$935	Not eligible	Covered for diabetes, varies by plan
Mounjaro	$1,070	Not eligible	Covered for diabetes, varies by plan
Rybelsus	$980	Not eligible	Covered for diabetes, varies by plan

For Ozempic, Mounjaro, and Rybelsus on standard Part D for diabetes, your actual copay depends on your specific plan's formulary tier and where you are in the coverage phases. Tier 3 copays typically run $40-80, with potentially higher costs if you are in the donut hole. The 2026 $2,100 annual out-of-pocket cap limits your maximum exposure.

For a deeper comparison of these medications, see our Ozempic vs Wegovy vs Zepbound guide.

Hidden Costs to Plan For

The $50 Bridge copay is the headline number, but factor in:

Doctor visits — typically every 3-6 months for monitoring, covered by Part B
Lab work — blood panels to check effects, covered by Part B
Pharmacy dispensing fees — minimal, usually $0-5
CGM (if diabetic) — if you are also using a continuous glucose monitor, that has separate coverage
Possible supplements — many GLP-1 patients add protein powders to hit muscle-preservation targets

Total real cost on the Bridge for most patients: $50-100/month all-in including indirect costs.

What Happens After the Bridge Ends?

The Bridge runs through December 31, 2027. If it is not renewed by Congress:

The $50 copay disappears
Wegovy would no longer be covered by Medicare Part D for weight loss
Your effective cost would jump from $50 to $1,300+ overnight

There is bipartisan interest in extending the Bridge or making it permanent, but no legislation has passed yet as of mid-2026. Treat the 18-month Bridge window as an opportunity to establish treatment, see results, and build the case for permanent coverage.

How to Get Started

Verify eligibility — take the free 2-minute quiz
Read the coverage guide — our Medicare & GLP-1 hub covers everything you need to know
Find a prescriber — use our Provider Directory to find a Medicare-friendly GLP-1 doctor in your area
Understand the process — read our GLP-1 prior authorization guide

Track Your Progress

Once you are on a GLP-1, the free CairnSpace tracker helps you log daily protein, hydration, symptoms, and weight — built specifically for people on GLP-1 medications. No sign-up fees, no ads.